ATLANTA, Ga., June 17, 2025 /PRNewswire/ -- Huxley Medical, a commercial-stage medical technology firm focused on streamlining detection of sleep and heart disorders, announced that the clinical ...

SANSA revealed sleep apnea during a daytime nap as well as overnight sleep, highlighting how typical overnight-only home sleep apnea testing may miss the full burden of disease and not capture ...

Credit: Huxley Medical. The SANSA patch is worn on the chest and contains sensors that measure 8 physiological channels. The SANSA patch is available by prescription only. The Food and Drug ...

"Cellular-enabled SANSA paves the way for sleep physicians and technicians to receive data in near real-time once a test is complete, enabling more efficient workflows and accelerating time to care.

Central sleep apnea validation: Promising SANSA diagnostic performance – Researchers developed and tested a new algorithm to detect central sleep apnea (CSA) using SANSA and compared results to in-lab ...

ATLANTA, Aug. 7, 2024 /PRNewswire/ -- Huxley Medical, a developer of technologies that streamline cardiopulmonary care, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) ...